IDST


Share

Program Content

Activities

  • (Neo)Adjuvant Tx HER2-Negative EBC
    (Neo)Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 06, 2023

    Expires: October 05, 2024

Faculty

cover img faculity

Denise A. Yardley

Sarah Cannon Research Institute
Senior Investigator, Breast Cancer Research
Tennessee Oncology, PLLC
Nashville, Tennessee

cover img faculity

Tanya Gupta, MD

Palo Alto Medical Foundation
Palo Alto, California

cover img faculity

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Tiffany A Traina, MD, FASCO

Associate Attending, Breast Medicine Service
Vice Chair, Department of Medicine
Section Head, TNBC Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

Smart Patients

ProCE Banner